Avricore Health And 2 Other TSX Penny Stocks To Watch

In This Article:

The Canadian market has been experiencing a period of growth, with the TSX reaching record highs alongside the S&P 500, driven by favorable economic fundamentals and a decisive U.S. election outcome that has cleared some uncertainties. In this context, investors might consider exploring penny stocks—smaller or newer companies that can offer surprising value despite their somewhat outdated label. By focusing on those with solid financial foundations and potential for growth, investors may find opportunities in these stocks that combine stability with the possibility of future upside.

Top 10 Penny Stocks In Canada

Name

Share Price

Market Cap

Financial Health Rating

PetroTal (TSX:TAL)

CA$0.65

CA$611.45M

★★★★★★

Amerigo Resources (TSX:ARG)

CA$1.65

CA$276.89M

★★★★★☆

Alvopetro Energy (TSXV:ALV)

CA$4.83

CA$179.38M

★★★★★★

Pulse Seismic (TSX:PSD)

CA$2.29

CA$117.05M

★★★★★★

Findev (TSXV:FDI)

CA$0.435

CA$12.18M

★★★★★☆

Mandalay Resources (TSX:MND)

CA$3.28

CA$311.11M

★★★★★★

Winshear Gold (TSXV:WINS)

CA$0.17

CA$4.87M

★★★★★★

Foraco International (TSX:FAR)

CA$2.22

CA$219.69M

★★★★★☆

NamSys (TSXV:CTZ)

CA$1.13

CA$30.36M

★★★★★★

East West Petroleum (TSXV:EW)

CA$0.035

CA$3.17M

★★★★★★

Click here to see the full list of 962 stocks from our TSX Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Avricore Health

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Avricore Health Inc. operates in the health data and point-of-care technologies sector in Canada with a market cap of CA$14.13 million.

Operations: The company generates revenue primarily from its Healthtab - Point of Care segment, which amounted to CA$4.48 million.

Market Cap: CA$14.13M

Avricore Health Inc., with a market cap of CA$14.13 million, operates in the health data and point-of-care technologies sector. Despite being unprofitable, the company has shown significant improvement by reducing losses at a rate of 30.2% annually over five years and achieving positive net income recently. Its short-term assets exceed liabilities, and it remains debt-free with no long-term liabilities. Avricore has a stable cash runway for more than three years due to positive free cash flow growth. Recent earnings reports highlight increased sales to CA$2.17 million for six months ending June 2024, indicating revenue growth potential despite current challenges.

TSXV:AVCR Revenue & Expenses Breakdown as at Nov 2024
TSXV:AVCR Revenue & Expenses Breakdown as at Nov 2024

Blockmint Technologies

Simply Wall St Financial Health Rating: ★★★★★★